IL17A and inflammatory bowel disease: Fujino et al. [18] were the first to demonstrate a positive correlation between elevated levels of IL-17 in the inflamed mucosa and active lesions of IBD patients, as well as elevated serum levels of IL-17 and disease activity in both CD and UC.